- Report of Foreign Issuer (6-K)
March 17 2009 - 12:51PM
Edgar (US Regulatory)
File No. 1-10905
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
VITRO, S.A.B.
DE C.V.
FORM 6-K
Report of Foreign
Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of
1934
For the month of March, 2009
(Filed March 17, 2009)
N/A
(Translation of
Registrant's Name into English)
Av. Ricardo Margain Zozaya 400
Garza
Garcia, NL
66250 Mexico
(52) 8863-1200
(Address of Principal Executive
Office)
Indicate by check mark whether the registrant files or
will file annual reports under cover of Form 20-F or Form 40-F
Form 20-F [ X ] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ]
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 107(b)(7): [ ]
Indicate by check mark whether the registrant by furnishing
the information contained in this form is also thereby furnishing
the information to the Commission pursuant to Rule 12g3-2(b) under
the Securities Exchange Act of 1934
Yes [ ] No [ X ]
CONTENTS
Documents Attached:
*
Press Information dated March 17, 2009
Release
Vitro Reached a Stay in Litigation Processes with Derivative Financial
Counterparties
San Pedro Garza Garcia, Nuevo Leon, Mexico, March 17, 2009.- Vitro, S.A.B. de C.V. (BMV: VITROA; NYSE: VTO),
announced today that has reached stay agreements with Credit Suisse, Calyon,
Merrill Lynch, Barclays and Citibank, counterparties of derivative financial
instruments.
In accordance with these stipulations, the parties have agreed to a continuance
of the deadline for the filling of Vitro's initial responsive pledging in the
Supreme Court of the State of New York and a stay of the litigation processes
until April 24, 2009, allowing parties time to negotiate solutions and reach a
satisfactory mutual and final agreements.
"As evidence by these stipulations,
which can be renovated if the parties agree, we will continue exploring
different alternatives and searching for creative ways to reach a favorable
settlement. We expect Deutsche Bank, the remaining derivative counterparty will
join today this amicable alternative in order to restructure our financial
obligations", said
Hugo Lara, CEO of
Vitro.
"These important steps confirm that viable solutions exist; we strongly believe in the
Company's potential to overcome this challenging environment", concluded Hugo
Lara.
Vitro, with 100 years of existence, has a strong foundation in place with solid business operations,
strong franchise and market positions and superior quality products. While these
negotiations take place, the Company will continue providing the quality
products and services its broadly diversified customers need, and also provide
it with the wherewithal to pay for the materials and services it needs to
manufacture such products. For many of our customers and suppliers these are
trying times as well and Vitro will be there to help them get through with its
continuous operation and production of quality products and services as it has
done in the past.
Vitro, S.A.B. de C.V. (BMV: VITROA; NYSE: VTO), is one of the largest glass manufacturers in the world. Through our subsidiary companies we offer
products with the highest quality standards and reliable services to satisfy the
needs of two distinct business sectors: glass containers and flat glass. Our
manufacturing facilities produce, process, distribute and sell a wide range of
glass products that offer excellent solutions to multiple industries that
include: wine, beer, cosmetic, pharmaceutical, food and beverage, as well as the
automotive and construction industry. Also, we supply raw materials, machinery
and industrial equipment to different industries. We constantly strive to
improve the quality of life for our employees as well as the communities in
which we do business by generating employment and economic prosperity thanks to
our permanent focus on quality and continuous improvement as well as consistent
efforts to promote sustainable development. Our World Headquarters are located
in Monterrey, Mexico where Vitro was founded in 1909 and now embarks major
facilities and a broad distribution network in ten countries in the Americas and
Europe. For more information, you can access Vitro's Website at:
http://www.vitro.com
For more information, please contact:
Media
Albert Chico Smith
Roberto Riva Palacio
Vitro, S. A. B. de C.V.
+52 (81) 8863-1661/ 1689
achico@vitro.com
rriva@vitro.com
|
Investor Relations
Adrian Meouchi /Angel Estrada
Vitro S.A.B. de C.V.
+ (52) 81-8863-1765 / 1730
ameouchi@vitro.com
aestradag@vitro.com
|
U.S. Agency
Susan Borinelli / Kay Breakstone
Breakstone Group
(646) 452-2334
sborinelli@breakstone-group.com
kbreakstone@breakstone-group.com
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on it's behalf by the undersigned,
thereunto duly authorized.
VITRO, S.A.B. DE C.V.
By
/s/ Claudio L. Del Valle Cabello
Name: Claudio L. Del Valle
Cabello
Title: Attorney in Fact
Date: March 17, 2009
Vitro Sociedad (NYSE:VTO)
Historical Stock Chart
From May 2024 to Jun 2024
Vitro Sociedad (NYSE:VTO)
Historical Stock Chart
From Jun 2023 to Jun 2024